The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines

doi 10.3386/w26120

Full Text

Abstract

Available in

Date

July 1, 2019

Authors

Publisher

National Bureau of Economic Research

Related search

Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation

English

Counterfeit Pharmaceuticals : Are the U.S. Consumers Aware of the Potential Risks?

English

The Promise of Specialty Pharmaceuticals: Are They Worth the Price?

Journal of Managed Care Pharmacy

English

Price Negotiation for Pharmaceuticals in Germany: High Influence of Eu Price Weighting Method

Value in Health

Occupational Health

English

The Effect of Different Price Promotion Ways on Consumers’ Purchasing Intention

American Journal of Industrial and Business Management

English

Competition in Pharmaceuticals: More Product- Than Price-Oriented?

European Journal of Health Economics

English

Access to Liposomal Generic Formulations: Beyond AmBisome and Doxil/Caelyx

English

Beyond a Fair Price

English

Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets

English